Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Interpretation of the Importance of Skeletal Muscle Mass on Prognosis and Recovery in Cardiac Arrest Survivors: From Machine Learning to Clinical Trial

NCT07034170 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07034170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Interpretation of the Importance of Skeletal Muscle Mass on Prognosis and Recovery in Cardiac Arrest Survivors: From Machine Learning to Clinical Trial
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
June 1, 2025
Completion date
December 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inhospital cardiac arrest, out of hospital cardiac arrest